Industry | 2020.10.12
Catalent to Discuss Innovative Approaches to Achieving T-Cell Commercial Readiness at Upcoming Industry Conference
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that Jesse Trekker, Ph.D., Business Director, Strategic Partnerships, Catalent Cell & Gene Therapy, will present at the Allogeneic Cell Therapies Summit, which will take place virtually on 26 – 28 October, 2020.
(PRWeb October 12, 2020)
Read the full story at https://www.prweb.com/releases/catalent_to_discuss_innovative_approaches_to_achieving_t_cell_commercial_readiness_at_upcoming_industry_conference/prweb17463900.htm
For more information, please visit
https://www.prweb.com/releases/catalent_[...]y_conference/prweb17463900.htm
